article thumbnail

Khosla Ventures’ Alex Morgan on biotech’s challenges and solving drug delivery

Bio Pharma Dive

The life sciences investor has backed a number of startups working on technologies for delivering and manufacturing cell and gene medicines.

article thumbnail

Kyowa Kirin backs €125m life science fund closed by Fountain Healthcare

pharmaphorum

Ireland-based Fountain Healthcare Partners has raised another €125 million ($131 million) for its third life sciences fund – 25% ahead of its target – and says it will pump most of the money into European therapeutics and medical device companies. The third fund is now closed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Unlocking the potential of mucoadhesive drug delivery

Drug Discovery World

Ashley Rein , Global Market Manager for Topical Drug Delivery at Lubrizol Life Science Health (LLS Health), explains how by using mucoadhesive drug delivery, developers can bring novel drugs to market and maximise the efficacy of pre-existing APIs. . Consider drug delivery systems early on .

article thumbnail

TriSalus Life Sciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of SD-101 via Pressure-Enabled Drug Delivery in Uveal Melanoma Liver Metastases

BioTech 365

TriSalus Life Sciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of SD-101 via Pressure-Enabled Drug Delivery in Uveal Melanoma Liver Metastases TriSalus Life Sciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of … Continue reading →

article thumbnail

Employee Retention and Motivation Strategies for Life Science Companies — Free Onboarding Checklist Included

XTalks

Employee retention and motivation is a challenge that all life science companies face. Life science companies often have to follow a complex regulatory framework that is associated with high risks, which is why maintaining corporate compliance is essential. Training and Development Opportunities.

article thumbnail

XBB.1.5 Omicron Subvariant + FDA Approves AstraZeneca’s New Asthma Inhaler – Xtalks Life Science Podcast Ep. 93

XTalks

Subscribe to the Xtalks Life Science Podcast to never miss a new episode. AstraZeneca’s Airsupra Approved as First-In-Class Combo Asthma Treatment. The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.

article thumbnail

FDA Authorizes Pfizer COVID-19 Vaccine for Children 5 to 11 + Genentech’s Ocular Implant for Macular Degeneration – Xtalks Life Science Podcast Ep. 35

XTalks

The team also learned about the FDA approval of Genentech’s new ocular implant drug delivery system, called Susvimo, for the treatment of neovascular, or wet, age-related macular degeneration (nAMD). Genentech’s New Ocular Implant Drug Delivery System for Macular Degeneration Could Be a Game Changer.